Clinical Trial Update: Memantine for Prevention of Cognitive Decline in Patients With Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating memantine to prevent cognitive decline in patients experiencing chemo-brain/Cognitive Decline after breast cancer treatment; study comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Chemo Brain
• Cognitive Decline

Drugs mentioned

• Memantine (memantine)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Cognitive Decline, Chemo-brain | Phase 2 | Status: COMPLETED | Results posted: 2023-04-20